A vertebral skeletal stem cell lineage driving metastasis
Vertebral bone is subject to a distinct set of disease processes from long bones, including a much higher rate of solid tumour metastases 1 – 4 . The basis for this distinct biology of vertebral bone has so far remained unknown. Here we identify a vertebral skeletal stem cell (vSSC) that co-expresse...
Saved in:
Published in | Nature (London) Vol. 621; no. 7979; pp. 602 - 609 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
21.09.2023
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Vertebral bone is subject to a distinct set of disease processes from long bones, including a much higher rate of solid tumour metastases
1
–
4
. The basis for this distinct biology of vertebral bone has so far remained unknown. Here we identify a vertebral skeletal stem cell (vSSC) that co-expresses ZIC1 and PAX1 together with additional cell surface markers. vSSCs display formal evidence of stemness, including self-renewal, label retention and sitting at the apex of their differentiation hierarchy. vSSCs are physiologic mediators of vertebral bone formation, as genetic blockade of the ability of vSSCs to generate osteoblasts results in defects in the vertebral neural arch and body. Human counterparts of vSSCs can be identified in vertebral endplate specimens and display a conserved differentiation hierarchy and stemness features. Multiple lines of evidence indicate that vSSCs contribute to the high rates of vertebral metastatic tropism observed in breast cancer, owing in part to increased secretion of the novel metastatic trophic factor MFGE8. Together, our results indicate that vSSCs are distinct from other skeletal stem cells and mediate the unique physiology and pathology of vertebrae, including contributing to the high rate of vertebral metastasis.
Vertebral osteoblasts in mouse and human are formed from a precursor skeletal stem cell population that is distinct from long bone skeletal stem cells in function, location and transcriptional programme. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 J.S. designed, conducted and analyzed the majority of experiments. M.B.G. supervised the project, and M.B.G. and J.S. conceived the project. J.S., L.H. and A.R.Y. performed all mouse surgeries. J.S., A.R.Y., L.Z., S.L., Z.L., N.L. and M.C. maintained and genotyped all mice. J.M., supervised or conducted flow cytometry. S.B. and Y.N. did the experimental repeats. S.I., D.S., A.P., S.D., M.H., V.J.S., M.P.G.B and K.M. supervised or conducted human specimen studies. V.M., V.J.S., L.W., W.Z., R.X. assisted J.S. in conducting tumor cell line tropism studies. J.S. and M.B.G. prepared the manuscript. All authors read and approved the manuscript. Author contributions |
ISSN: | 0028-0836 1476-4687 1476-4687 |
DOI: | 10.1038/s41586-023-06519-1 |